A.W. Salman et al. / Polyhedron 81 (2014) 499–510
501
(500 MHz, d6-DMSO) d: 0.91 (6H, d J = 6.5 Hz, NCH2CH2CH(CH3)2),
2.01–2.10 (1H, m, NCH2CH2CH(CH3)2), 3.35 (2H, quart J = 5.5 Hz,
NCH2CH2CH(CH3)2), 4.72 (2H, t J = 6.0 Hz,NCH2CH2CH(CH3)2), 5.91
(2H, s, benzylic CH2), 7.11–7.20 (5H, m, benzyl-H), 7.65–7.73 (2H,
m, benzimidazole-H), 8.0–8.09 (2H, m, benzimidazole-H), 9.92
(H, s, benzimidazole-H20). 13C{1H} NMR (125 MHz, d6-DMSO) d:
12.2 (NCH2CH2CH(CH3)2), 21.7 (NCH2CH2CH(CH3)2), 28.4
(NCH2CH2CH(CH3)2), 51.2 (NCH2CH2CH(CH3)2), 52.7 (benzylicCH2),
116.6, 118.3, 124.2, 134.7 (Ar-C benzyl), 117.5, 122.7, 124.0, 133.5,
135.0, (Ar-C benzimidazole), 139.4 (benzimidazolium C20). FT-IR
(2H, m, NCH2CH2CH2CH3), 1.85–1.92 (2H, m, NCH2CH2CH2CH3),
4.76 (4H, t, J = 7.2 Hz, NCH2CH2CH2CH3), 7.32 (3H, t J = 5.5 Hz,
benzimidazolium-H), 7.73 (2H, d J = 6.0 Hz, benzimidazolium-H),
8.23–8.30 (5H, m, benzyl-H), 9.01 (2H, s, benzimidazolium H20).
13C{1H} NMR (125 MHz, D2O) d: 11.8 (NCH2CH2CH2CH3), 21.0
(NCH2CH2CH2CH3), 33.5 (NCH2CH2CH2CH3), 50.6 (NCH2CH2CH2
CH3), 116.3, 123.2, 127.0, 133.0 (Ar-C benzimidazole), 137.3 (benz-
imidazolium C20), 162.0 (cyanuric NCN), 164.4, 164.9 (cyanuric
2 ꢁ C-O). FT-IR (KBr disc) cmꢀ1: ꢂ2950, ꢂ2830 (C–H), 1613
(C@Nbenzimid), 1621 (C@Ntriazine), 1034, ꢂ1080 (Carom–Nbenzimid).
Anal. Calc. for C14H15N5O2: C, 58.9; H, 5.3; N, 24.5. Found: C,
59.3; H, 5.6; N, 24.1%.
(KBr disc) cmꢀ1: ꢂ2930, 2867
m(C–H), 1622 m(C@N, benzimid-
azole), ꢂ1050
m(C–N, benzimidazole). Anal. Calc. for C19H23N2Br:
C, 63.5; H, 6.4; N, 7.8. Found: C, 63.3; H, 6.0; 7.3%.
2.2.6. Synthesis of bis-[1-benzyl-3-(20-methyl)propylbenzimidazolium]
silver(I) bromide (6)
2.2.3. Synthesis of 1-benzyl-3-hexylbenzimidazolium bromide (3)
This compound was prepared in a manner analogous to that for
1, only with n-hexyl bromide (0.198 g, 1.2 mmol) instead of
2-methylpropyl bromide. Yield: 83.1%. M.P.: 144–145 °C. 1H NMR
(500 MHz, d6-DMSO) d: 0.85 (3H, t J = 7.2 Hz, N(CH2)5CH3), 1.30–
1.40 (2H, m, N(CH2)4CH2CH3), 2.11–2.28 (2H, quart, N(CH2)3
CH2CH2CH3), 2.87–2.95 (2H, quart, N(CH2)2CH2(CH2)2CH3), 3.60–
3.67 (2H, quart, NCH2CH2(CH2)3CH3), 4.74 (2H, t J = 6.4 Hz, NCH2
(CH2)4CH3), 5.77 (2H, s, benzylic CH2), 7.16–7.23 (3H, m, benzyl-
H), 7.30–7.36 (2H, m, benzyl-H), 7.65 (2H, t J = 7.2 Hz, benzimid-
azole-H), 8.21–8.30 (2H, m, benzimidazole-H), 10.05 (H, s,
benzimidazole-H20). 13C{1H} NMR (125 MHz, d6-DMSO) d: 11.6
(N(CH2)5CH3), 19.3 (N(CH2)4CH2CH3), 23.7 (N(CH2)3CH2CH2CH3),
27.8 (N(CH2)2CH2(CH2)2CH3), 35.2 (NCH2CH2(CH2)3CH3), 51.6
(NCH2(CH2)4CH3), 52.8 (benzylicCH2), 117.6, 119.1, 125.5, 133.4
(Ar-C benzyl), 118.7, 123.4, 132.6, 135.3, (Ar-C benzimidazole),
137.7 (benzimidazolium C20). FT-IR (KBr disc) cmꢀ1: 2939, ꢂ2870
To a stirred solution of the benzimidazolium salt 1 (0.347 g,
1 mmol) in methanol (25 mL) was added silver(I) oxide (0.126 g,
0.055 mmol) in a 50 mL round-bottom flask. The reaction mixture
was allowed to stir at room temperature for 48 h in the dark, after
which the reaction mixture was filtered through a bed of Celite to
remove unreacted silver(I) oxide. The solvent was then removed
in vacuo, leaving a colorless solid which was washed with diethyl
ether (3 ꢁ 5 mL) and recrystallized from methanol/diethyl ether.
Yield: 52.1%. M.P.: 223–224 °C. 1H NMR (500 MHz, d6-DMSO) d:
0.97 (12H, d J = 7.2 Hz, 2 ꢁ NCH2CH(CH3)2), 1.96–2.05 (2H, m,
2 ꢁ NCH2CH(CH3)2), 4.43 (4H, t J = 6.8 Hz,2 ꢁ NCH2CH(CH3)2), 5.38
(4H, s, benzylic CH2), 7.20–7.28 (10H, m, benzyl-H), 7.50–7.58
(4H, m, benzimidazole-H), 7.91–8.01 (4H, m, benzimidazole-H).
13C{1H} NMR (125 MHz, d6-DMSO) d: 12.2 (NCH2CH(CH3)2), 20.7
(NCH2CH(CH3)2), 51.1 (NCH2CH(CH3)2), 52.3 (benzylic CH2), 117.3,
122.3, 124.9, 133.8 (Ar-C benzyl), 116.1, 120.8, 123.6, 134.3,
m
(C–H), 1628
m(C@N, benzimidazole), 1064
m
(C–N, benzimidazole).
135.3,
(Ar-C
benzimidazole),
179.7
(benzimidazolium
(C–H), 1594 (C@N,
Anal. Calc. for C20H25N2Br: C, 64.3; H, 6.7; N, 7.5. Found: C, 64.7; H,
6.3; 7.8%.
C20-Ag). FT-IR (KBr disc) cmꢀ1: ꢂ2925, 2838
m
m
benzimidazole), 1012 m(C–N, benzimidazole). Anal. Calc. for
C36H40N4AgBr: C, 60.3; H, 5.6; N, 7.8. Found: C, 60.5; H, 6.0; 7.9%.
2.2.4. Synthesis of 4-(3-butyl-2,3-dihydro-imidazol-1-yl)-
[1,3,5]triazin-2,4-diol anion (4)
2.2.7. Synthesis of bis-[1-benzyl-3-(20-methyl)butylbenzimidazolium]
silver(I) bromide (7)
1-Butylimidazole (0.124 g, 1 mmol) in 20 mL of dry acetone was
placed in a 150 mL round bottom flask connected to N2 gas and
equipped with a stirrer. The flask was immersed in an ice bath
and cyanuric chloride (0.183 g, 1 mmol) in 20 mL of dry acetone
was added dropwise over 30 min. An off-white precipitate formed
after the complete addition. The stirring was continued for another
2 h under the same reaction conditions and then for 4 h at room
temperature. The precipitate that formed was collected by filtra-
tion, washed with fresh acetone (2 ꢁ 5 mL) and dried in a vacuum
desiccator. Yield: 68.5%. M.P.: >300 °C. 1H NMR (500 MHz, D2O) d:
0.83 (3H, t, J = 6.2 Hz, NCH2CH2CH2CH3), 1.28–1.37 (2H, m,
NCH2CH2CH2CH3), 1.83–1.91 (2H, m, NCH2CH2CH2CH3), 4.33 (4H,
t, J = 6.5 Hz, NCH2CH2CH2CH3), 7.58 (2H, d, J = 6.0 Hz, imidazolium
H50), 7.97 (2H, d, J = 6.0 Hz, imidazolium H40), 8.91 (2H, s, imidazo-
lium H20). 13C{1H} NMR (125 MHz, D2O) d: 13.3 (NCH2CH2CH2CH3),
20.2 (NCH2CH2CH2CH3), 30.8 (NCH2CH2CH2CH3), 51.8 (NCH2
CH2CH2CH3), 122.2, 124.7 (imidazolium C50 and C40), 136.1
(imidazolium C20), 160.3 (cyanuric NCN), 163.1, 164.7 (cyanuric
2 ꢁ C-O). FT-IR (KBr disc) cmꢀ1: 2933, ꢂ2875 (C–H), ꢂ1615
(C@Nimid), 1628 (C@Ntriazine), ꢂ1045, 1083 (Carom–Nimid). Anal. Calc.
for C10H13N5O2: C, 51.1; H, 5.6; N, 29.8. Found: C, 50.7; H, 5.6; N,
30.1%.
This complex was prepared in a manner analogous to that for
complex 6, only with the benzimidazolium salt
2 (0.359 g,
1.0 mmol) instead of salt 1. Further work up and purification of this
complex were done in a methanol/n-hexane mixture. Yield: 48.4%.
M.P.: >300 °C. 1H NMR (500 MHz, d6-DMSO) d: 1.01 (12H, d
J = 6.5 Hz, 2 ꢁ NCH2CH2CH(CH3)2), 2.01–2.10 (2H, m, 2 ꢁ NCH2CH2
CH(CH3)2), 3.41 (4H, quart J = 5.5 Hz, 2 ꢁ NCH2CH2CH(CH3)2), 4.79
(4H, t J = 6.2 Hz,2 ꢁ NCH2CH2CH(CH3)2), 5.96 (4H, s, 2 ꢁ benzylic
CH2), 7.24–7.32 (10H, m, benzyl-H), 7.72–7.81 (2H, m, benzimid-
azole-H), 8.11–8.19 (2H, m, benzimidazole-H). 13C{1H} NMR
(125 MHz, d6-DMSO) d: 11.0 (NCH2CH2CH(CH3)2), 22.2 (NCH2CH2
CH(CH3)2), 30.1 (NCH2CH2CH(CH3)2), 51.5 (NCH2CH2CH(CH3)2),
52.7 (benzylic CH2), 118.4, 119.8, 123.3, 133.0 (Ar-C benzyl),
116.6, 123.9, 125.1, 132.0, 134.2 (Ar-C benzimidazole), 181.5
(benzimidazolium C20-Ag). FT-IR (KBr disc) cmꢀ1: 2933, ꢂ2875
m
(C–H), 1582
m
(C@N, benzimidazole), ꢂ1010
m(C–N, benzimid-
azole). Anal. Calc. for C38H44N2AgBr: C, 61.3; H, 6.0; N, 7.5. Found:
C, 61.0; H, 6.3; 7.2%.
2.2.8. Synthesis of bis-[1-benzyl-3-hexylbenzimidazolium]silver(I)
bromide (8)
This complex was prepared in a manner analogous to that for
2.2.5. Synthesis of 4-(3-butyl-2,3-dihydro-benzimidazol-1-yl)-
[1,3,5]triazin-2,4-diol anion (5)
This compound was prepared in a manner analogous to that for
4, only with 1-butybenzlimidazole (0.175 g, 1 mmol) instead of
1-butylimidazole. Yield: 72.7%. M.P.: >300 °C. 1H NMR (500 MHz,
D2O) d: 0.91 (3H, t, J = 6.6 Hz, NCH2CH2CH2CH3), 1.32–1.39
complex 6, only with the benzimidazolium salt 3 (0.373 g,
1.0 mmol) instead of salt 1. Further work up and purification of this
complex were done in a methanol/n-hexane mixture. Yield: 57.7%.
M.P.: >300 °C. 1H NMR (500 MHz, d6-DMSO) d: 0.92 (6H,
t
J = 6.8 Hz, 2 ꢁ N(CH2)5CH3), 1.26–1.35 (4H, m, 2 ꢁ N(CH2)4
CH2CH3), 2.17–2.24 (4H, quart, 2 ꢁ N(CH2)3CH2CH2CH3),